153 related articles for article (PubMed ID: 37406396)
21. Cell death markers in patients with cirrhosis and acute decompensation.
Macdonald S; Andreola F; Bachtiger P; Amoros A; Pavesi M; Mookerjee R; Zheng YB; Gronbaek H; Gerbes AL; Sola E; Caraceni P; Moreau R; Gines P; Arroyo V; Jalan R
Hepatology; 2018 Mar; 67(3):989-1002. PubMed ID: 29023872
[TBL] [Abstract][Full Text] [Related]
22. Correlation of myeloid-derived suppressor cells with C-reactive protein, ferritin and lactate dehydrogenase levels in patients with severe COVID-19.
Emsen A; Sumer S; Tulek B; Cizmecioglu H; Vatansev H; Goktepe MH; Kanat F; Koksal Y; Arslan U; Artac H
Scand J Immunol; 2022 Jan; 95(1):e13108. PubMed ID: 34625989
[TBL] [Abstract][Full Text] [Related]
23. Vulnerability to recurrent episodes of acute decompensation/acute-on-chronic liver failure characterizes those triggered by indeterminate precipitants in patients with liver cirrhosis.
Hoshi H; Chu PS; Yoshida A; Taniki N; Morikawa R; Yamataka K; Noguchi F; Kasuga R; Tabuchi T; Ebinuma H; Saito H; Kanai T; Nakamoto N
PLoS One; 2021; 16(4):e0250062. PubMed ID: 33848309
[TBL] [Abstract][Full Text] [Related]
24. Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis.
Liu YF; Zhuang KH; Chen B; Li PW; Zhou X; Jiang H; Zhong LM; Liu FB
Arthritis Res Ther; 2018 Aug; 20(1):168. PubMed ID: 30075733
[TBL] [Abstract][Full Text] [Related]
25. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.
Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L
Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030
[TBL] [Abstract][Full Text] [Related]
26. Single center validation of mortality scores in patients with acute decompensation of cirrhosis with and without acute-on-chronic liver failure.
Alexopoulou A; Vasilieva L; Mani I; Agiasotelli D; Pantelidaki H; Dourakis SP
Scand J Gastroenterol; 2017 Dec; 52(12):1385-1390. PubMed ID: 28851246
[TBL] [Abstract][Full Text] [Related]
27. [Current pathophysiological concepts of acute decompensation in patients with liver cirrhosis and prognostic scores in different stages of disease].
Sturm L; Reincke M; Bettinger D
Dtsch Med Wochenschr; 2022 Jun; 147(11):662-669. PubMed ID: 35636416
[TBL] [Abstract][Full Text] [Related]
28. Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome.
Dhiman RK; Agrawal S; Gupta T; Duseja A; Chawla Y
World J Gastroenterol; 2014 Oct; 20(40):14934-41. PubMed ID: 25356054
[TBL] [Abstract][Full Text] [Related]
29. Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure.
Blaya D; Pose E; Coll M; Lozano JJ; Graupera I; Schierwagen R; Jansen C; Castro P; Fernandez S; Sidorova J; Vasa-Nicotera M; Solà E; Caballería J; Trebicka J; Ginès P; Sancho-Bru P
JHEP Rep; 2021 Apr; 3(2):100233. PubMed ID: 33665588
[TBL] [Abstract][Full Text] [Related]
30. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.
Moreau R; Jalan R; Gines P; Pavesi M; Angeli P; Cordoba J; Durand F; Gustot T; Saliba F; Domenicali M; Gerbes A; Wendon J; Alessandria C; Laleman W; Zeuzem S; Trebicka J; Bernardi M; Arroyo V;
Gastroenterology; 2013 Jun; 144(7):1426-37, 1437.e1-9. PubMed ID: 23474284
[TBL] [Abstract][Full Text] [Related]
31. Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas.
Singh B; Singh DK; Ganatra SR; Escobedo RA; Khader S; Schlesinger LS; Kaushal D; Mehra S
mBio; 2021 Dec; 12(6):e0318921. PubMed ID: 34903057
[TBL] [Abstract][Full Text] [Related]
32. Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma.
Zhong LM; Liu ZG; Zhou X; Song SH; Weng GY; Wen Y; Liu FB; Cao DL; Liu YF
Oral Oncol; 2019 Aug; 95():157-163. PubMed ID: 31345384
[TBL] [Abstract][Full Text] [Related]
33. Polymorphonuclear myeloid-derived suppressor cells link inflammation and damage response after trauma.
Li X; Liu J; Xing Z; Tang J; Sun H; Zhang X; Lv S; Chen Z; Shi M; Chen M; Zuo S; Lyu X; He Y
J Leukoc Biol; 2021 Dec; 110(6):1143-1161. PubMed ID: 34636072
[TBL] [Abstract][Full Text] [Related]
34. Impaired myeloid-derived suppressor cells are associated with recurrent implantation failure: A case-control study.
Jiang H; Zhu M; Guo P; Bi K; Lu Z; Li C; Zhai M; Wang K; Cao Y
J Reprod Immunol; 2021 Jun; 145():103316. PubMed ID: 33866110
[TBL] [Abstract][Full Text] [Related]
35. Elevated neopterin levels are associated with acute-on-chronic liver failure and mortality in patients with liver cirrhosis.
Matiollo C; Rateke ECM; de Oliveira KG; Turnes BL; da Silva TE; Maccali C; Latini AS; Narciso-Schiavon JL; Schiavon LL
Dig Liver Dis; 2020 Jul; 52(7):753-760. PubMed ID: 32434738
[TBL] [Abstract][Full Text] [Related]
36. Complement C3 Facilitates Stratification of Stages of Chronic Hepatitis B and Signifies Development of Acute-on-Chronic Liver Failure in Acute Decompensated Cirrhosis.
Chen C; Yuan Z; Li W; Fei L; Ji L; Huang Q; Zhang S; Chen L
Adv Ther; 2023 Mar; 40(3):1171-1186. PubMed ID: 36652176
[TBL] [Abstract][Full Text] [Related]
37. Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF).
Mezzano G; Cárdenas A; Aguilar F; Pavesi M; Solé C; Napoleone L; Graupera I; Juanola A; Carol M; Pose E; Fabrellas N; Hernaez R; Martínez J; Saliba F; Arroyo V; Sola E; Gines P
Dig Liver Dis; 2021 Jun; 53(6):738-745. PubMed ID: 33446445
[TBL] [Abstract][Full Text] [Related]
38. Prognostic assessment of liver cirrhosis and its complications: current concepts and future perspectives.
Gülcicegi DE; Goeser T; Kasper P
Front Med (Lausanne); 2023; 10():1268102. PubMed ID: 37780566
[TBL] [Abstract][Full Text] [Related]
39. Expansion of Polymorphonuclear Myeloid-Derived Suppressor Cells in Patients With Gout.
Zhong L; Li S; Wen Y; Zheng J; Liu F; Cao D; Liu Y
Front Immunol; 2020; 11():567783. PubMed ID: 33154749
[TBL] [Abstract][Full Text] [Related]
40. Expansion of polymorphonuclear myeloid-derived suppressor cells in patients with end-stage renal disease may lead to infectious complications.
Xing YF; Cai RM; Lin Q; Ye QJ; Ren JH; Yin LH; Li X
Kidney Int; 2017 May; 91(5):1236-1242. PubMed ID: 28215666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
